A potentially significant role for the MAPK signaling pathway (hsa04010) was identified, and six high-risk genes (BCL2, KRAS, MAPK14, VEGFA, RAF1, and ESR1) and associated lncRNA-SNPs in MG patients were revealed. The gene discussed is BCL2; the disease is myasthenia gravis.